Literature DB >> 17660506

Pulmonary and systemic immune response to inhaled multiwalled carbon nanotubes.

Leah A Mitchell1, Jun Gao, Randy Vander Wal, Andrew Gigliotti, Scott W Burchiel, Jacob D McDonald.   

Abstract

Inhalation of multiwalled carbon nanotubes (MWCNTs) at particle concentrations ranging from 0.3 to 5 mg/m3 did not result in significant lung inflammation or tissue damage, but caused systemic immune function alterations. C57BL/6 adult (10- to 12-week) male mice were exposed by whole-body inhalation to control air or 0.3, 1, or 5 mg/m3 respirable aggregates of MWCNTs for 7 or 14 days (6 h/day). Histopathology of lungs from exposed animals showed alveolar macrophages containing black particles; however, there was no inflammation or tissue damage observed. Bronchial alveolar lavage fluid also demonstrated particle-laden macrophages; however, white blood cell counts were not increased compared to controls. MWCNT exposures to 0.3 mg/m3 and higher particle concentrations caused nonmonotonic systemic immunosuppression after 14 days but not after 7 days. Immunosuppression was characterized by reduced T-cell-dependent antibody response to sheep erythrocytes as well as T-cell proliferative ability in presence of mitogen, Concanavalin A. Assessment of nonspecific natural killer (NK) cell activity showed that animals exposed to 1 mg/m(3) had decreased NK cell function. Gene expression analysis of selected cytokines and an indicator of oxidative stress were assessed in lung tissue and spleen. No changes in gene expression were observed in lung; however, interleukin-10 (IL-10) and NAD(P)H oxidoreductase 1 mRNA levels were increased in spleen.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17660506     DOI: 10.1093/toxsci/kfm196

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  108 in total

Review 1.  Nanoparticles as a potential cause of pleural and interstitial lung disease.

Authors:  James C Bonner
Journal:  Proc Am Thorac Soc       Date:  2010-05

Review 2.  The new toxicology of sophisticated materials: nanotoxicology and beyond.

Authors:  Andrew D Maynard; David B Warheit; Martin A Philbert
Journal:  Toxicol Sci       Date:  2010-12-22       Impact factor: 4.849

3.  Exposure to nanoparticles and hormesis.

Authors:  Ivo Iavicoli; Edward J Calabrese; Marc A Nascarella
Journal:  Dose Response       Date:  2010-08-12       Impact factor: 2.658

Review 4.  Pulmonary applications and toxicity of engineered nanoparticles.

Authors:  Jeffrey W Card; Darryl C Zeldin; James C Bonner; Earle R Nestmann
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-07-18       Impact factor: 5.464

5.  Nanotoxicology: How do nanotubes suppress T cells?

Authors:  Alison Elder
Journal:  Nat Nanotechnol       Date:  2009-06-14       Impact factor: 39.213

Review 6.  Perturbation of pulmonary immune functions by carbon nanotubes and susceptibility to microbial infection.

Authors:  Brent E Walling; Gee W Lau
Journal:  J Microbiol       Date:  2014-03-01       Impact factor: 3.422

Review 7.  Nanoparticles, lung injury, and the role of oxidant stress.

Authors:  Amy K Madl; Laurel E Plummer; Christopher Carosino; Kent E Pinkerton
Journal:  Annu Rev Physiol       Date:  2013-11-06       Impact factor: 19.318

Review 8.  From immunotoxicity to nanotherapy: the effects of nanomaterials on the immune system.

Authors:  Matthew J Smith; Jared M Brown; William C Zamboni; Nigel J Walker
Journal:  Toxicol Sci       Date:  2014-01-15       Impact factor: 4.849

9.  Carcinogenic Potential of High Aspect Ratio Carbon Nanomaterials.

Authors:  Sudjit Luanpitpong; Liying Wang; Donna C Davidson; Heimo Riedel; Yon Rojanasakul
Journal:  Environ Sci Nano       Date:  2016-04-06

10.  Measurement of mass-based carbon nanotube penetration through filtering facepiece respirator filtering media.

Authors:  Evanly Vo; Ziqing Zhuang; Eileen Birch; Qi Zhao; Matthew Horvatin; Yuewei Liu
Journal:  Ann Occup Hyg       Date:  2014-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.